STOCK TITAN

Director at Codexis (CDXS) receives 66,350 stock options grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CODEXIS, INC. director Cynthia Collins received a grant of stock options covering 66,350 shares of common stock at an exercise price of $2.48 per share. The options vest in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, and expire in 2036.

Positive

  • None.

Negative

  • None.
Insider Collins Cynthia
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 66,350 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 66,350 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Option grant size 66,350 options Stock Option (Right to Buy) awarded to director on 2026-06-17
Exercise price $2.48 per share Conversion or exercise price of stock option grant
Underlying shares 66,350 shares Underlying Codexis common stock linked to the option award
Post-transaction options held 66,350 options Total derivative securities following this grant
Option expiration date June 17, 2036 Expiration of Stock Option (Right to Buy)
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 2.4800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"This option vests and becomes exercisable with respect to all of the shares"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual stockholder meeting financial
"on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting"
An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Collins Cynthia

(Last)(First)(Middle)
C/O CODEXIS, INC.
200 PENOBSCOT DRIVE

(Street)
REDWOOD CITY CALIFORNIA 94063

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CODEXIS, INC. [ CDXS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$2.4806/17/2026A66,350 (1)06/17/2036Common Stock66,350$066,350D
Explanation of Responses:
1. This option vests and becomes exercisable with respect to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date.
/s/ Georgia Erbez, as Attorney-in-Fact for Cynthia Collins06/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Codexis (CDXS) director Cynthia Collins receive in this Form 4 filing?

Cynthia Collins received a grant of stock options for 66,350 shares of Codexis common stock. These options are a compensation-related award and give her the right to buy shares at a fixed $2.48 exercise price before the options expire in 2036.

What is the exercise price of Cynthia Collins’ new Codexis (CDXS) stock options?

The exercise price of the new stock options is $2.48 per share. This means Collins can purchase Codexis common stock at $2.48 once the options vest, any time before they expire on June 17, 2036, subject to the vesting conditions being satisfied.

When do Cynthia Collins’ Codexis (CDXS) stock options vest according to the Form 4?

The options vest and become exercisable in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting. Vesting also requires that Collins continues to serve as a director on the applicable vesting date for the award.

How many Codexis (CDXS) options does Cynthia Collins hold after this transaction?

After this grant, Collins holds 66,350 stock options according to the Form 4. These options are linked to an equal number of underlying Codexis common shares and represent her position from this reported award, with no other derivative positions shown here.

Is Cynthia Collins buying or selling Codexis (CDXS) shares in this Form 4?

Collins is not buying or selling shares on the open market in this filing. Instead, she is receiving a grant of 66,350 stock options as a director award, a common form of equity compensation, with a $2.48 exercise price and vesting tied to continued service.